Delivery Order SPE2DB22D3501-SPE2DB25FVF86
- Not listed
- The Defense Logistics Agency awarded a $21,950 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF Redi-Ject 900 Unit 1.44ML, a pharmaceutical product used in fertility treatment. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and is not designated as a set-aside contract. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $31,639.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product used in fertility treatment. The award, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, represents a non-competitive delivery order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a $30,760.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.44ML, a pharmaceutical product used in fertility treatment. This non-set-aside award, issued on July 18, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency (DLA) awarded a $78,014.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Gonal-F RFF Redi-Ject 900 Unit 1.44mL, a pharmaceutical product used in fertility treatment. The contract, awarded on September 16, 2025, with a completion date of September 17, 2025, was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $38,412.50 for GONAL-F RFF Redi-Ject 900 Unit 1.44ML, a pharmaceutical product, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Department's Medical Supply Chain awarded a $28,361.19 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of GONAL-F RFF Redi-Ject 450 Unit 0.72ML pharmaceutical product. The contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. Performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania, with completion scheduled for August...
- On July 22, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $40,816.93 to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.44ML pharmaceutical products. This firm fixed-price, non-set-aside delivery order is scheduled for completion by July 23, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of GONAL-F RFF Redi-Ject 900 Unit 1.44ML, a pharmaceutical product, with a ceiling value of $10,975.00. Issued on September 9, 2025, with an ultimate completion date of September 10, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $21,950 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of GONAL-F RFF Redi-Ject 900 Unit 1.44ML pharmaceutical products. This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GONAL-F RFF Redi-Ject 900 Unit 1.44ML pharmaceutical product with a ceiling value of $33,834.30. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract was competitively awarded without set-aside provisions, reflecting...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVF86Delivery Order
The Defense Logistics Agency awarded a $10,975 delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a fertility medication used in assisted reproductive treatments. This firm fixed price delivery order, issued on April 10, 2025, with an ultimate completion date of April 11, 2025, represents a non-set-aside competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and specialized medical commodities across multiple therapeutic areas. AmerisourceBergen's consistent receipt of competitive awards demonstrates its capability to fulfill federal medical supply requirements through open competition, supporting critical healthcare needs for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 4/10/25 |